Holly Lindsay

11PUBLICATIONS
183CO-AUTHORS
Infant and child healthMolecular targetsCentral nervous systemNanotoxicology, health and safetyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 30, 2026
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG.

|May 26, 2026
A first-in-pediatric study of ALRN-6924, a novel stapled-peptide dual MDM2/MDMX inhibitor, for children with advanced hematologic and solid malignancies.

|Dec 03, 2024
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions.

Audrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle

|Jul 23, 2024
Toxicity profile of high-dose methotrexate in young children with central nervous system tumors.

Ashley N Chavana, Zachary L Taylor, Nicholas DeGroote

|Jun 25, 2024
The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma.

Mohammad H Abu-Arja, Austin L Brown, Jack M Su

|Jun 07, 2024
SNO pediatric molecular tumor board series: Successful beginnings and future directions.

Holly B Lindsay, Craig Erker, Suzanne Laughlin

Pageof 2

Frequent Collaborators

2 joint publications

Nathan J Robison

2 joint publications

Eugene I Hwang

2 joint publications

Craig Erker

2 joint publications

Donald Williams Parsons